From Concept to Commercialisation is one of the key partnership areas in which ELC GROUP is creating its fast-growing success.
From the development stage through to the implementation of clinical trials, completion of product registration, and successful marketing of the product, ELC GROUP aligns itself as a strategic partner to help pharmaceutical companies achieve their healthcare goals.
News
Pharma eReport delivers V5-compliant solution to help MAHs meet December 31st XEVMPD resubmission deadline - 15th September 2014
Centrality software is fully compliant with EMA V5 schema updates and available now to pharmaceutical Marketing Authorisation Holders More
ELC Group Appoints Dr. Siddharth Chachad as Head of Global Clinical Development and Medical Affairs - 20th August 2014
Internationally acclaimed clinical pharmacologist joins global regulatory affairs specialist in key management post More
ELC Group Appoints Head of Regulatory Affairs for Russia and CIS - 28th July 2014
Inna Demidova to head new Moscow office for fast-growing global regulatory affairs specialist More
Case Studies
Referral Management Service
When this generic international pharmaceutical company found its promising pan-European license application suddenly encountering an unexpected problem, it turned to ELC to navigate the complex referral process and get back on track to achieve the all-important approvals it needed to go to market.
Scientific Advice Service
When an Asia-based pharmaceutical company wanted to speed time-to-market for its generic to a leading brand-name drug, it engaged ELC Group to help to get the product successfully launched in European markets on its first submission – and as the first in its market.
Complete Pharmacovigilance
Solution
A generic pharmaceutical company looked to ELC Group’s experience and expert knowledge to help reduce operational costs, meet key regulatory deadlines and ensure continuing compliance across its global portfolio of products.